Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
GOLIMUMAB ADMINISTERED SUBCUTANEOUSLY EVERY 4 WEEKS IN ACTIVE RHEUMATOID ARTHRITIS DESPITE METHOTREXATE: WEEK 24 RESULTS OF GO-FORWARD STUDY Rubbert, A., Keystone, E., Genovese, M., Klareskog, L., Hsia, E. C., Zrubek, J., Wu, Z., Rahman, M. U., GO-FORWARD Study Investigators OXFORD UNIV PRESS. 2009: I92
View details for Web of Science ID 000266198600301